Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $91.72
- Average 1Y price target
- $109.50+19.39%
- Agreement
- Good
Analysts agreement range is spread less than 15% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall4
- DCF4
- Return on equity4
- Return on assets4
- Debt / equity3
- P/E4
- P/B4
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 2 | $109.50 |
| Last quarter | 3 | $112.33 |
| Last year | 10 | $119.20 |
| All time | 22 | $128.50 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 14, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| Oct 5, 2026 | UBS | maintain | Neutral | Neutral |
| Aug 5, 2026 | UBS | maintain | Neutral | Neutral |
| Aug 5, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| Jun 9, 2026 | Oppenheimer | downgrade | Outperform | Perform |
| May 6, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| Apr 22, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Apr 9, 2026 | UBS | maintain | Neutral | Neutral |
| Feb 5, 2026 | UBS | maintain | Neutral | Neutral |
| Feb 4, 2026 | Stephens & Co. | maintain | Equal Weight | Equal Weight |
| Feb 4, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| Nov 6, 2025 | Barclays | downgrade | Overweight | Equal Weight |
| Nov 5, 2025 | UBS | maintain | Neutral | Neutral |
| Nov 5, 2025 | Stephens & Co. | maintain | Equal Weight | Equal Weight |
| Nov 5, 2025 | BMO Capital | maintain | Market Perform | Market Perform |
| Oct 6, 2025 | UBS | maintain | Neutral | Neutral |
| Jul 9, 2025 | UBS | maintain | Neutral | Neutral |
| Apr 22, 2025 | Oppenheimer | maintain | Outperform | Outperform |
| Apr 7, 2025 | UBS | downgrade | Buy | Neutral |
| Feb 5, 2025 | Stephens & Co. | maintain | Equal Weight | Equal Weight |
| Feb 5, 2025 | Oppenheimer | maintain | Outperform | Outperform |
| Feb 5, 2025 | BMO Capital | maintain | Market Perform | Market Perform |
| Nov 15, 2024 | UBS | maintain | Buy | Buy |
| Nov 6, 2024 | Oppenheimer | maintain | Outperform | Outperform |
| Nov 6, 2024 | BMO Capital | maintain | Market Perform | Market Perform |
| Nov 6, 2024 | Barclays | maintain | Overweight | Overweight |
| Oct 21, 2024 | Oppenheimer | maintain | Outperform | Outperform |
| Aug 15, 2024 | UBS | maintain | Buy | Buy |
| Aug 9, 2024 | Barclays | upgrade | Equal Weight | Overweight |
| Aug 7, 2024 | Oppenheimer | maintain | Outperform | Outperform |
| Aug 7, 2024 | BMO Capital | maintain | Market Perform | Market Perform |
| May 9, 2024 | BMO Capital | maintain | Market Perform | Market Perform |
| Mar 6, 2024 | Barclays | maintain | Equal Weight | Equal Weight |
| Feb 16, 2024 | Goldman Sachs | maintain | Buy | Buy |
| Feb 15, 2024 | Goldman Sachs | upgrade | Neutral | Buy |
| Feb 7, 2024 | Stephens & Co. | maintain | Overweight | Overweight |
| Nov 13, 2023 | UBS | maintain | Buy | Buy |
| Nov 8, 2023 | Stephens & Co. | maintain | Overweight | Overweight |
| Nov 1, 2023 | Barclays | maintain | Equal Weight | Equal Weight |
| Aug 9, 2023 | Stephens & Co. | maintain | Overweight | Overweight |